Acetyl-L-Carnitine
Also known as: ALC, acetylcarnitine, acetyl-L-carnitine
Systematic reviews and guideline documents identify a large trial literature but show inconsistent effects. Older meta-analyses suggested possible benefit on some dementia clinical global measures, but later and larger trials failed to confirm robust cognitive benefit. Reviews of neuropathy and hepatic encephalopathy report mixed evidence; some meta-analyses examined small trials and the safety signal for chemotherapy-induced peripheral neuropathy prompted recommendations against its use in that setting.
Last reviewed: 2026-10-14 · 5 indexed studies
Set your location for accurate regulatory status
Saved on this device — no sign-in needed.
Overview
Acetyl-L-carnitine (ALC) is an acetylated form of carnitine used as an oral nutraceutical for cognitive symptoms, neuropathic pain, and liver-related encephalopathy. Clinical evidence from systematic reviews and guidelines is mixed: some older dementia trials suggested benefit while later, larger trials were not supportive, and guidance warns against use in chemotherapy-induced peripheral neuropathy.
Mechanism & Function
Mechanism of Action
ALC is proposed to support mitochondrial function, modulate cholinergic neurotransmission, and influence neuronal membrane stability; these mechanisms could plausibly affect cognition and neuropathic symptoms, but clinical translation is inconsistent across indications according to available reviews.
Physiological Role
Serves as an acetyl donor and facilitator of fatty acid transport into mitochondria; may affect acetylcholine metabolism and neuronal energy metabolism.
Primary Pathways
Performance / Health Relevance
Direct evidence for ergogenic effects (exercise performance, strength, endurance) is not represented in the provided clinical reviews and guidelines; clinical research in humans focuses on cognition, neuropathy and hepatic encephalopathy rather than athletic performance.
Evidence Review
Practical Use & Dosage
- Minimum Effective Dose
- Not established from the provided abstracts
- Optimal Range
- Not established from the provided abstracts
- Upper / Caution Level
- Not established from the provided abstracts
- Timing
- Not established from the provided abstracts
- Best Format
- Oral formulations (capsules/tablets) as used in clinical trials
- Bioavailability
- Acetylation may increase central nervous system availability relative to L-carnitine, but specific bioavailability data are not provided in the abstracts
- Absorption Considerations
- Not specified in the provided abstracts
Safety & Interactions
Side Effects
- •Possible worsening of chemotherapy‑induced peripheral neuropathy reported in some analyses
- •General tolerability data not detailed in provided abstracts
Contraindications
- Use in patients receiving neurotoxic chemotherapy should be avoided based on guideline recommendation noting potential harm
Drug Interactions
- •Not specified in the provided abstracts
Who Should Avoid
- •People undergoing neurotoxic chemotherapy (due to recommended avoidance for prevention of chemotherapy‑induced peripheral neuropathy)
Monitoring
Monitor neuropathic symptoms if used in populations at risk of chemotherapy‑induced neuropathy; otherwise follow clinical monitoring appropriate to the treated condition.
Frequently Asked Questions
Auto-generated from indexed evidence — dosage, safety, interactions, and more.
When is Acetyl-L-Carnitine typically used or indicated?
Acetyl-L-Carnitine is most commonly used for: Cognitive support / age-related cognitive decline, Peripheral neuropathy (including diabetic and chemotherapy-induced), Hepatic encephalopathy adjunctive treatment, General mitochondrial support / energy metabolism. Serves as an acetyl donor and facilitator of fatty acid transport into mitochondria; may affect acetylcholine metabolism and neuronal energy metabolism.
How does Acetyl-L-Carnitine work?
ALC is proposed to support mitochondrial function, modulate cholinergic neurotransmission, and influence neuronal membrane stability; these mechanisms could plausibly affect cognition and neuropathic symptoms, but clinical translation is inconsistent across indications according to available reviews.
What is the recommended dose of Acetyl-L-Carnitine?
The optimal range is Not established from the provided abstracts. with a minimum effective dose of Not established from the provided abstracts. Best taken: Not established from the provided abstracts. Upper / caution level: Not established from the provided abstracts.
What are the side effects of Acetyl-L-Carnitine?
Reported side effects include: Possible worsening of chemotherapy‑induced peripheral neuropathy reported in some analyses; and General tolerability data not detailed in provided abstracts. Monitoring: Monitor neuropathic symptoms if used in populations at risk of chemotherapy‑induced neuropathy; otherwise follow clinical monitoring appropriate to the treated condition.
Does Acetyl-L-Carnitine interact with medications?
Known or theoretical interactions: Not specified in the provided abstracts. Always check with a clinician before combining with prescription medication.
Who should avoid Acetyl-L-Carnitine?
Acetyl-L-Carnitine is generally not recommended for: People undergoing neurotoxic chemotherapy (due to recommended avoidance for prevention of chemotherapy‑induced peripheral neuropathy); and Use in patients receiving neurotoxic chemotherapy should be avoided based on guideline recommendation noting potential harm.
How strong is the evidence for Acetyl-L-Carnitine?
Evidence level: Limited (overall score 46/100), based on 5 indexed studies on SuppIndex.
Research & References (5)
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce.
International guideline/taskforce reviewing nutraceuticals for psychiatric disorders, assessing levels of evidence across nutraceuticals including acetyl-L-carnitine and providing clinical recommendations based on meta-analyses and RCTs.
Acetyl-L-carnitine for dementia.
Systematic review of randomized double-blind trials of ALC in people with Alzheimer's disease (11 trials).
Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.
Society for Integrative Oncology clinical practice guidelines reviewing integrative therapies during/after breast cancer treatment.
Acetyl-L-carnitine for patients with hepatic encephalopathy.
Cochrane systematic review and meta-analysis of acetyl-L-carnitine for hepatic encephalopathy.
The role of diet and non-pharmacologic supplements in the treatment of chronic neuropathic pain: A systematic review.
Systematic review of diet and non-pharmacologic supplements in chronic neuropathic pain, categorising studies by pain type and noting ALC among interventions studied for diabetic and chemotherapy-induced peripheral neuropathy.
Related Ingredients
Other top-rated ingredients in Nootropics.
Caffeine Anhydrous
90/100Methylxanthine alkaloid; non-selective adenosine A1/A2A receptor antagonist; raises cAMP, catecholamine release, and Ca²⁺ sensitivity in muscle.
Alpha-GPC
78/100Highly bioavailable choline donor that elevates brain acetylcholine levels, supporting memory, learning, and muscular power output via enhanced neuromuscular junction signaling.
L-Theanine
72/100A non-proteinogenic amino acid analog of glutamate that crosses the BBB, promoting alpha-wave brain activity and modulating inhibitory neurotransmitter balance.
Research Overview
Limited EvidenceCite this ingredient
One-click citation export in APA, MLA, Chicago, BibTeX, or HTML. The URL below is stable and safe to link.
Stable URL
https://thesuppindex.com/ingredients/acetyl-l-carnitine
SuppIndex. (2026). Acetyl-L-Carnitine: Evidence summary, dosage and clinical studies. Retrieved October 16, 2026, from https://thesuppindex.com/ingredients/acetyl-l-carnitine
Based on 5 indexed studies · Evidence level: Limited.
Goal Ratings
Stack Compatibility
No specific interactions described in the provided abstracts; standard caution when combining with other neuroactive agents.